These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 8642091)

  • 1. Leishmaniasis.
    Grevelink SA; Lerner EA
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):257-72. PubMed ID: 8642091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
    Zijlstra EE
    PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmaniasis as an emerging infection.
    Choi CM; Lerner EA
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):175-82. PubMed ID: 11924824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leishmaniasis in children. Recent progress].
    Carrada-Bravo T
    Bol Med Hosp Infant Mex; 1984 Jul; 41(7):356-62. PubMed ID: 6477699
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous Manifestations of Human and Murine Leishmaniasis.
    Scorza BM; Carvalho EM; Wilson ME
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL).
    Volpedo G; Pacheco-Fernandez T; Holcomb EA; Cipriano N; Cox B; Satoskar AR
    Front Cell Infect Microbiol; 2021; 11():685296. PubMed ID: 34169006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leishmaniasis].
    Kemp M; Theander TG
    Ugeskr Laeger; 2000 Nov; 162(46):6203-7. PubMed ID: 11107967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leishmaniasis with cutaneous and visceral involvement in a 13-month old boy].
    Landmann E; Bogdan C; Donhauser N; Artlich A; Staude B; Gortner L
    Klin Padiatr; 2000; 212(5):266-7. PubMed ID: 11048286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania and HIV co-infection: dermatological manifestations.
    Puig L; Pradinaud R
    Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():107-14. PubMed ID: 14678638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histology of cutaneous leishmaniasis].
    Mokni M; Mebazaa A; Boubaker S
    Ann Dermatol Venereol; 2011; 138(4):354-6. PubMed ID: 21497266
    [No Abstract]   [Full Text] [Related]  

  • 11. Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients.
    Singh A; Ramesh V; Ramam M
    Indian J Dermatol Venereol Leprol; 2015; 81(1):29-34. PubMed ID: 25566893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent leishmaniasis in kidney transplant recipients: report of 2 cases and systematic review of the literature.
    Simon I; Wissing KM; Del Marmol V; Antinori S; Remmelink M; Nilufer Broeders E; Nortier JL; Corbellino M; Abramowicz D; Cascio A
    Transpl Infect Dis; 2011 Aug; 13(4):397-406. PubMed ID: 21281418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney involvement in leishmaniasis--a review.
    Silva Junior GB; Barros EJ; Daher Ede F
    Braz J Infect Dis; 2014; 18(4):434-40. PubMed ID: 24690431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L. (L.) chagasi in AIDS and visceral leishmaniasis (kala-azar) co-infection.
    Roselino AM; Chociay MF; Costa RS; Machado AA; Figueiredo JF
    Rev Inst Med Trop Sao Paulo; 2008; 50(4):251-4. PubMed ID: 18813767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective primary health care: strategies for control of disease in the developing world. XIV. Leishmaniasis.
    Marsden PD
    Rev Infect Dis; 1984; 6(5):736-44. PubMed ID: 6095406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widespread atypical cutaneous Leishmaniasis caused by Leishmania (L.) Chagasi in Nicaragua.
    Belli A; García D; Palacios X; Rodriguez B; Valle S; Videa E; Tinoco E; Marín F; Harris E
    Am J Trop Med Hyg; 1999 Sep; 61(3):380-5. PubMed ID: 10497975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lingual leishmaniasis complicating visceral disease.
    Mazumder SA; Pandey S; Brewer SC; Baselski VS; Weina PJ; Land MA; Fleckenstein JM
    J Travel Med; 2010; 17(3):212-4. PubMed ID: 20536896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 1993; 87(4):425-7. PubMed ID: 8249072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmaniasis: recognition and management with a focus on the immunocompromised patient.
    Choi CM; Lerner EA
    Am J Clin Dermatol; 2002; 3(2):91-105. PubMed ID: 11893221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous, mucocutaneous and visceral leishmaniasis in Sweden from 1996-2016: a retrospective study of clinical characteristics, treatments and outcomes.
    Glans H; Dotevall L; Söbirk SK; Färnert A; Bradley M
    BMC Infect Dis; 2018 Dec; 18(1):632. PubMed ID: 30526519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.